According to IDEAYA Biosciences's latest financial reports the company has a price-to-book ratio of 4.81.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2023-12-31 | 3.69 | 47.61% |
2022-12-31 | 2.50 | -17.19% |
2021-12-31 | 3.02 | 44.86% |
2020-12-31 | 2.09 | 37.27% |
2019-12-31 | 1.52 | |
2018-12-31 | N/A |
Company | P/B ratio | differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | 2.43 | -49.53% | ๐บ๐ธ USA |